Aaron I. Davis, Director at iTeos Therapeutics, Inc. (ITOS), bought 53,700 shares at $33.43 ($1.7M) on 2022-03-22, disclosed to the SEC on 2022-03-24.
Open-market purchase of $1.7M ITOS by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.88 | 21,300 | $679K | 38.8% |
| 2 | $33.09 | 3,700 | $122K | 7.0% |
| 3 | $33.09 | 3,700 | $122K | 7.0% |
| 4 | $33.43 | 5,000 | $167K | 9.6% |
| 5 | $32.85 | 20,000 | $657K | 37.6% |
| Total | $32.55 avg | 53,700 |
| $1.7M |
| 100% |
| Filing → |
| TYRA | SELL | 2023-02-13 | $4.4M | — | Filing → |
| RAIN | BUY | 2022-11-08 | $11.3M | — | Filing → |
| ITOS | SELL | 2022-05-11 | $20.2M | — | Filing → |